Anavex Life Sciences Corp. Company Profile (NASDAQ:AVXL)

About Anavex Life Sciences Corp.

Anavex Life Sciences Corp. logoAnavex Life Sciences Corp., is a clinical-stage biopharmaceutical company engaged in the development of drug candidates. The Company's lead compounds include ANAVEX 2-73, ANAVEX PLUS, a combination of ANAVEX 2-73 with donepezil (Aricept), ANAVEX 19-144, ANAVEX 1-41, ANAVEX 7-1037, ANAVEX 3-71, ANAVEX 1079, ANAVEX 1519 and ANAVEX 1066 being developed to treat Alzheimer's disease and other central nervous system (CNS) diseases. The Company's SIGMACEPTOR Discovery Platform produced small molecule drug candidates with unique modes of action. Sigma receptors may be targets for therapeutics to combat many human diseases, including Alzheimer's disease. When bound by the appropriate ligands, sigma receptors influence the functioning of multiple biochemical signals that are involved in the pathogenesis (origin or development) of disease.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AVXL
  • CUSIP:
Key Metrics:
  • Previous Close: $3.65
  • 50 Day Moving Average: $3.09
  • 200 Day Moving Average: $4.55
  • 52-Week Range: $2.43 - $14.84
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.25
  • P/E Growth: 0.00
  • Market Cap: $130.34M
  • Outstanding Shares: 35,710,000
  • Beta: -0.32
Profitability:
  • Return on Equity: -132.18%
  • Return on Assets: -107.02%
Debt:
  • Current Ratio: 4.53%
  • Quick Ratio: 4.53%
Additional Links:
Companies Related to Anavex Life Sciences Corp.:

Analyst Ratings

Consensus Ratings for Anavex Life Sciences Corp. (NASDAQ:AVXL) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $12.50 (244.35% upside)

Analysts' Ratings History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Show:
DateFirmActionRatingPrice TargetDetails
9/29/2016FBR & CoSet Price TargetBuy$10.00View Rating Details
7/27/2016Maxim GroupSet Price TargetBuy$15.00View Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/15/2016        
8/11/2016Q316($0.09)($0.06)ViewN/AView Earnings Details
5/11/2016Q2($0.16)($0.06)ViewN/AView Earnings Details
2/8/2016Q116($0.12)ViewN/AView Earnings Details
12/29/2015Q4($0.06)($0.65)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Current Year EPS Consensus Estimate: $-0.34 EPS
Next Year EPS Consensus Estimate: $-0.44 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.14)($0.14)($0.14)
Q2 20161($0.14)($0.14)($0.14)
Q3 20161($0.09)($0.09)($0.09)
Q4 20161($0.08)($0.08)($0.08)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Insider Ownership Percentage: 9.37%
Institutional Ownership Percentage: 10.72%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/14/2015Christopher U MisslingCEOBuy1,000$0.52$520.00View SEC Filing  
7/13/2015Christopher U MisslingCEOBuy1,000$0.53$530.00View SEC Filing  
7/7/2015Christopher U MisslingCEOBuy2,000$0.49$980.00View SEC Filing  
7/1/2015Christopher U MisslingCEOBuy2,000$0.45$900.00View SEC Filing  
6/23/2015Christopher U MisslingCEOBuy1,000$0.47$470.00View SEC Filing  
6/22/2015Christopher U MisslingCEOBuy1,000$0.42$420.00View SEC Filing  
6/16/2015Christopher U MisslingCEOBuy1,000$0.44$440.00View SEC Filing  
6/15/2015Christopher U MisslingCEOBuy1,000$0.43$430.00View SEC Filing  
6/10/2015Christopher U MisslingCEOBuy1,000$0.36$360.00View SEC Filing  
6/8/2015Christopher U MisslingCEOBuy1,000$0.35$350.00View SEC Filing  
6/4/2015Christopher U MisslingCEOBuy1,000$0.37$370.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Anavex Life Sciences Corp. (NASDAQ:AVXL)
DateHeadline
4-traders.com logoAnavex Life Sciences : Compound to be Tested in Biogen Neurological Protection Model (NASDAQ:AVXL)
www.4-traders.com - September 30 at 8:57 AM
smarteranalyst.com logoFBR Reiterates Outperfom on Anavex Life Sciences Corp. (AVXL) Following Agreement with Biogen (NASDAQ:AVXL)
www.smarteranalyst.com - September 30 at 8:57 AM
News IconAnavex Life Sciences Corp. (NASDAQ:AVXL), Biogen Inc (NASDAQ:BIIB) Sign Material Transfer Deal For ANAVEX 2-73 (NASDAQ:AVXL)
www.journaltranscript.com - September 30 at 8:57 AM
News Icon2 Stocks Attracting Analyst Attention: Patterson Companies, Inc. (NASDAQ:PDCO), Anavex Life Sciences Corp ... - The Voice Registrar (NASDAQ:AVXL)
voiceregistrar.com - September 29 at 3:53 PM
benzinga.com logoANAVEX LIFE SCIENCES (AVXL), SkyPeople Fruit Juice, Inc ... - Benzinga (NASDAQ:AVXL)
www.benzinga.com - September 29 at 8:46 AM
News IconBiogen to Test Anavex’s Lead Drug Candidate (NASDAQ:AVXL)
www.pharmalive.com - September 28 at 3:46 PM
seekingalpha.com logoAnavex up 45% on Biogen deal (NASDAQ:AVXL)
seekingalpha.com - September 28 at 3:46 PM
finance.yahoo.com logoAnavex Soars on Biogen Agreement (NASDAQ:AVXL)
finance.yahoo.com - September 28 at 3:46 PM
schaeffersresearch.com logoAnavex Life Sciences Corp. (AVXL) Rally Sends Stock, Options Volumes Toward Highs (NASDAQ:AVXL)
www.schaeffersresearch.com - September 28 at 3:46 PM
thestreet.com logo4 Big-Volume Stocks to Add to Your Buy List -- Plus 3 to Avoid (NASDAQ:AVXL)
www.thestreet.com - September 28 at 3:46 PM
fool.com logoWhy Anavex Life Sciences Corp. Rocketed Higher Today (NASDAQ:AVXL)
www.fool.com - September 28 at 2:51 PM
investorplace.com logoAnavex Life Sciences Corp. (AVXL) Scores Big on Biogen Test (NASDAQ:AVXL)
investorplace.com - September 28 at 2:00 PM
benzinga.com logo18 Stocks Moving In Wednesday's Pre-Market Session - Benzinga (NASDAQ:AVXL)
www.benzinga.com - September 28 at 8:28 AM
streetinsider.com logoBiogen (BIIB) to Test Anavex Life Sciences (AVXL) Lead Drug Candidate ANAVEX 2-73 - StreetInsider.com (NASDAQ:AVXL)
www.streetinsider.com - September 28 at 8:28 AM
finance.yahoo.com logoAnavex Compound to be Tested in Biogen Neurological Protection Model (NASDAQ:AVXL)
finance.yahoo.com - September 28 at 8:28 AM
News Icon2 Stocks Analyst-Opinion Need Close Attention Lattice Semiconductor (NASDAQ:LSCC), Anavex Life Sciences Corp ... - The Voice Registrar (NASDAQ:AVXL)
voiceregistrar.com - September 27 at 3:39 PM
News IconAnavex Life Sciences Corp. (NASDAQ:AVXL): The Start Of A Long Term Run? (NASDAQ:AVXL)
streetregister.com - September 25 at 3:28 PM
benzinga.com logoAnavex Life Sciences Jumps 28% After Promising Results From Parkinson's Trial - Benzinga (NASDAQ:AVXL)
www.benzinga.com - September 24 at 8:59 AM
investopedia.com logoAnnex Shows Positive Parkinson's Drug Data (AVXL) (NASDAQ:AVXL)
www.investopedia.com - September 24 at 8:59 AM
News IconGreat Basin Scientific Inc (NASDAQ:GBSN) & Anavex Life Sciences Corp. (NASDAQ:AVXL) Stocks Buzz - Money News (NASDAQ:AVXL)
www.newsismoney.com - September 23 at 4:05 PM
smarteranalyst.com logoFBR Weighs in on Anavex Life Sciences Corp. (AVXL) Following Positive Preclinical Data - Smarter Analyst (NASDAQ:AVXL)
www.smarteranalyst.com - September 23 at 4:05 PM
istreetwire.com logoStocks Roundup: Southwestern Energy Company (SWN), Anavex Life Sciences Corp. (AVXL), Netflix, Inc. (NFLX) - iStreetWire (NASDAQ:AVXL)
istreetwire.com - September 23 at 8:43 AM
News IconStock Seen Gapping Up Pre-Bell: Anavex Life Sciences Corp ... - Post News (NASDAQ:AVXL)
www.kentuckypostnews.com - September 23 at 8:43 AM
feeds.benzinga.com logoAnavex Life Sciences Jumps 28% After Promising Results From Parkinson's Trial (NASDAQ:AVXL)
feeds.benzinga.com - September 22 at 5:17 PM
streetinsider.com logoUnusual 11 Mid-Day Movers 9/22: (HTCH) (WCIC) (SAEX) Higher; (AXON) (OMN) (LBIX) Lower - StreetInsider.com (NASDAQ:AVXL)
www.streetinsider.com - September 22 at 3:46 PM
streetinsider.com logoPre-Open Stock Movers 09/22: (WCIC) (AVXL) (NVAX) Higher; (MLHR) (JBL) (CPK) Lower (more...) - StreetInsider.com (NASDAQ:AVXL)
www.streetinsider.com - September 22 at 3:46 PM
schaeffersresearch.com logoAnavex Life Sciences Corp. (AVXL) Soars on Parkinson's Drug Data - Schaeffers Research (blog) (NASDAQ:AVXL)
www.schaeffersresearch.com - September 22 at 3:46 PM
fxpips.com logoThese Stocks are Gapping Up after the Bell – NAII, GLMD, AVXL, WINT, MCRB, DTSI, PBYI (NASDAQ:AVXL)
www.fxpips.com - September 22 at 9:33 AM
4-traders.com logoAnavex Life Sciences : to Present at Ladenburg Thalmann 2016 Healthcare Conference (NASDAQ:AVXL)
www.4-traders.com - September 22 at 9:33 AM
nasdaq.com logoAnavex Life Sciences’ Drug Shows Efficacy to Support Potential Disease Modification in Parkinson’s Disease (NASDAQ:AVXL)
www.nasdaq.com - September 22 at 9:33 AM
streetinsider.com logoAnavex Life Sciences (AVXL) ANAVEX 2-73 Preclincal Data Shows Efficacy in Parkinson's Disease (NASDAQ:AVXL)
www.streetinsider.com - September 22 at 9:33 AM
News IconExpert's Viewpoint for: Vonage Holdings Corp. (NYSE:VG) , Anavex Life Sciences Corp.'s (AVXL) - Wall Street Times (press release) (NASDAQ:AVXL)
www.wallstreetnews24.com - September 21 at 4:34 PM
News IconBiotech Stocks Worth a Closer Look: TetraLogic Pharmaceuticals Corporation (NASDAQ:TLOG), Anavex Life Sciences ... - The Voice Registrar (NASDAQ:AVXL)
voiceregistrar.com - September 21 at 4:34 PM
capitalcube.com logoAnavex Life Sciences Corp. :AVXL-US: Earnings Analysis: Q3, 2016 By the Numbers : September 20, 2016 (NASDAQ:AVXL)
www.capitalcube.com - September 20 at 3:40 PM
finance.yahoo.com logoAnavex to Present at Ladenburg Thalmann 2016 Healthcare Conference (NASDAQ:AVXL)
finance.yahoo.com - September 20 at 9:37 AM
News IconKeen Investors Seek Information on Anavex Life Sciences Corp. (:AVXL) - Duncan Research (NASDAQ:AVXL)
www.duncanindependent.com - September 17 at 8:29 AM
News IconAnavex Life Sciences Corp. (AVXL) Stock Price Down 1.6% - NewsDen (NASDAQ:AVXL)
newsden.net - September 16 at 3:39 PM
seekingalpha.com logoAvoid Anavex: Massive Dilution Ahead (NASDAQ:AVXL)
seekingalpha.com - September 15 at 9:07 PM
News IconStock Update, a Closer Look at Anavex Life Sciences Corp. (:AVXL) - Duncan Research (NASDAQ:AVXL)
www.duncanindependent.com - September 15 at 4:00 PM
seekingalpha.com logoAvoid Anavex: Massive Dilution Ahead - Seeking Alpha (NASDAQ:AVXL)
seekingalpha.com - September 14 at 3:42 PM
finance.yahoo.com logoAnavex to Participate in Mizuho Therapeutics Conference (NASDAQ:AVXL)
finance.yahoo.com - September 14 at 3:42 PM
streetinsider.com logoUnusual 11 Mid-Day Movers 9/13: (NYMX) (LMCA) (ISIL) Higher; (AGTC) (AVXL) (INAP) Lower - StreetInsider.com (NASDAQ:AVXL)
www.streetinsider.com - September 13 at 3:55 PM
News IconAnalyst Watch-list: Belden Inc (NYSE:BDC) , Anavex Life Sciences ... - Wall Street Times (press release) (NASDAQ:AVXL)
www.wallstreetnews24.com - September 12 at 3:38 PM
News IconAnavex: Hidden Debt Gives Heightened Urgency To Equity Raise - ValueWalk (NASDAQ:AVXL)
www.valuewalk.com - September 7 at 3:41 PM
finance.yahoo.com logoANAVEX LIFE SCIENCES CORP. Financials (NASDAQ:AVXL)
finance.yahoo.com - August 19 at 4:18 PM
smarteranalyst.com logoFBR Bullish on Anavex Life Sciences Corp. (AVXL) in Light of Positive Corporate and Pipeline Updates - Smarter Analyst (NASDAQ:AVXL)
www.smarteranalyst.com - August 17 at 3:46 PM
News IconTechnical Roundup on Biotech Stocks -- Anavex Life Sciences, Threshold Pharma, StemCells, and Aratana Therapeutics (NASDAQ:AVXL)
www.kswo.com - August 17 at 11:54 AM
News IconAnavex Life Sciences Corp. (NASDAQ:AVXL) Is Down But Not Out - Street Register (NASDAQ:AVXL)
streetregister.com - August 16 at 3:47 PM
News IconAnavex Life Sciences Corp. (NASDAQ:AVXL) Is Down But Not Out - Street Register (NASDAQ:AVXL)
streetregister.com - August 16 at 3:47 PM
News IconAnavex Life Sciences Corp. (NASDAQ:AVXL) Is Down But Not Out (NASDAQ:AVXL)
streetregister.com - August 16 at 12:20 PM

Social

Anavex Life Sciences Corp. (NASDAQ:AVXL) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff